Literature DB >> 21072847

Expression of mucin (MUC) genes in mucoepidermoid carcinoma.

Nima Shemirani1, Vladimir Osipov, Alex Kolker, Pawjai Khampang, Joseph E Kerschner.   

Abstract

OBJECTIVES/HYPOTHESIS: Mucoepidermoid carcinoma (MEC) is the most common malignant salivary gland tumor. The presence of mucin (MUC) genes has been correlated with patient prognosis using immunohistochemical techniques. This study was undertaken to 1) investigate the expression of newly discovered MUC genes in MEC specimens, 2) assess the correlation of this expression to prognosis, and 3) further investigate the correlation of previously identified MUC genes to prognosis using molecular techniques. STUDY
DESIGN: Retrospective chart review and sample isolation.
METHODS: Twenty-three patients with a diagnosis of MEC underwent mucin gene analysis of tumor and normal surrounding salivary gland tissue. Initial expression analysis of recently identified mucin genes MUC 12, 13, 17, 18, and 19 was performed using reverse transcription-polymerase chain reaction (RT-PCR) followed by quantitative assessment with quantitative PCR. Additional assessments of mucin genes MUC 1 and MUC 4, which have previously been associated with MEC, were also analyzed with real-time RT-PCR.
RESULTS: MEC was associated with MUC 19 expression in 65% of tumor samples compared to only 26% of normal tissue (P = .02). MUC 18 demonstrated equal expression in both tumor and normal tissue. MUC 12 and 17 were not expressed in either MEC or normal salivary gland. MUC 13 was found in 13% of tumors and 0% of normal samples. MUC 1 and MUC 4 were expressed 4.2- and 21-fold higher in stage I disease in tumor tissue compared to normal, respectively.
CONCLUSIONS: Presence of MUC 19 is suggestive of mucoepidermoid carcinoma, and higher expression of MUC 1 and MUC 4 is correlated with earlier stage disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21072847      PMCID: PMC4226649          DOI: 10.1002/lary.21164

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  11 in total

1.  MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications.

Authors:  Adriana Handra-Luca; Georges Lamas; Jacques-Charles Bertrand; Pierre Fouret
Journal:  Am J Surg Pathol       Date:  2005-07       Impact factor: 6.394

2.  Prognostic immunohistochemical markers of primary human melanomas.

Authors:  H Ostmeier; B Fuchs; F Otto; R Mawick; A Lippold; V Krieg; L Suter
Journal:  Br J Dermatol       Date:  2001-08       Impact factor: 9.302

3.  Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands.

Authors:  Llucia Alos; Blanca Lujan; Mireia Castillo; Alfons Nadal; Marta Carreras; Miguel Caballero; Carme de Bolos; Antonio Cardesa
Journal:  Am J Surg Pathol       Date:  2005-06       Impact factor: 6.394

4.  Chinchilla middle ear epithelial mucin gene expression in response to inflammatory cytokines.

Authors:  Joseph E Kerschner; Tanya K Meyer; Amy Burrows
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-10

5.  Genome-wide search and identification of a novel gel-forming mucin MUC19/Muc19 in glandular tissues.

Authors:  Yin Chen; Yu Hua Zhao; Tejas Baba Kalaslavadi; Edward Hamati; Keith Nehrke; Anh Dao Le; David K Ann; Reen Wu
Journal:  Am J Respir Cell Mol Biol       Date:  2003-07-25       Impact factor: 6.914

6.  Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience.

Authors:  Derek Kofi O Boahene; Kerry D Olsen; Jean E Lewis; A Daniel Pinheiro; Vernon Shane Pankratz; Stephanie M Bagniewski
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-07

7.  Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands.

Authors:  H Nagel; R Laskawi; H Eiffert; T Schlott
Journal:  Mol Pathol       Date:  2003-08

8.  Prognostic factors in head and neck mucoepidermoid carcinoma.

Authors:  Fábio Ramôa Pires; Oslei Paes de Almeida; Vera Cavalcanti de Araújo; Luiz Paulo Kowalski
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-02

9.  A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.

Authors:  Eric C McGary; Amy Heimberger; Lisa Mills; Kristy Weber; Gary W Thomas; Mikhail Shtivelband; Dina Chelouche Lev; Menashe Bar-Eli
Journal:  Clin Cancer Res       Date:  2003-12-15       Impact factor: 12.531

10.  Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.

Authors:  Guang-Jer Wu; Qiong Peng; Pingping Fu; Shur-Wern Wang; Cheng-Feng Chiang; Dirck L Dillehay; Mei-Whey H Wu
Journal:  Gene       Date:  2004-03-03       Impact factor: 3.688

View more
  5 in total

Review 1.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

2.  Expression of Topoisomerase II-α protein in salivary gland tumors.

Authors:  Asaf Shvero; Ohad Hilly; Golan Bubis; Yaniv Hamzany; Rumelia Koren; Lea Rath-Wolfson
Journal:  Mol Clin Oncol       Date:  2017-10-20

3.  Prognostic impact of MUC1 and potential regulatory miR-145 and miR-21 expression in salivary mucoepidermoid carcinoma.

Authors:  Ali Abdolrahmani; Neda Kardouni Khoozestani; Farid Azmoudeh-Ardalan; Ahmad Reza Shamshiri
Journal:  Head Neck Pathol       Date:  2022-08-18

4.  Expression of Mucins in Salivary Gland Mucoepidermoid Carcinoma.

Authors:  Liam Robinson; Marlene B van Heerden; Jason G Ker-Fox; Keith D Hunter; Willie F P van Heerden
Journal:  Head Neck Pathol       Date:  2020-09-21

Review 5.  Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases.

Authors:  Santosh Kumar Behera; Ardhendu Bhusan Praharaj; Budheswar Dehury; Sapna Negi
Journal:  Glycoconj J       Date:  2015-08-04       Impact factor: 3.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.